1. Home
  2. NTRA vs ROL Comparison

NTRA vs ROL Comparison

Compare NTRA & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$231.21

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Logo Rollins Inc.

ROL

Rollins Inc.

HOLD

Current Price

$63.14

Market Cap

29.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
ROL
Founded
2003
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Diversified Commercial Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
29.0B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
ROL
Price
$231.21
$63.14
Analyst Decision
Strong Buy
Buy
Analyst Count
15
10
Target Price
$249.53
$67.10
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
02-26-2026
02-11-2026
Dividend Yield
N/A
1.16%
EPS Growth
N/A
9.81
EPS
N/A
1.06
Revenue
$2,116,676,000.00
$3,680,306,000.00
Revenue This Year
$33.77
$12.52
Revenue Next Year
$16.92
$9.49
P/E Ratio
N/A
$59.19
Revenue Growth
38.17
11.17
52 Week Low
$125.38
$48.70
52 Week High
$256.36
$63.84

Technical Indicators

Market Signals
Indicator
NTRA
ROL
Relative Strength Index (RSI) 44.72 63.68
Support Level $229.14 $62.09
Resistance Level $250.00 $63.34
Average True Range (ATR) 8.27 0.89
MACD -1.38 0.05
Stochastic Oscillator 21.29 79.15

Price Performance

Historical Comparison
NTRA
ROL

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. They also have a litany of other brands, which they use to pursue customers via alternative sales channels. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

Share on Social Networks: